Update To Anti-Lesbian Drug?

Margie Nichols, Ph.D.by Margie Nichols, Ph.D.

By coincidence, as the news about a drug that can ‘de-masculinize’ female fetuses hit the blogs, one of my sex therapy listserves began a fascinating discourse about the prevalence of PCOS in female to male transgender people.  Polycystic Ovary Syndrome (PCOS) is a genetically transmitted syndrome with some potentially distressing symptoms and consequences.  However, in the population of young women presenting themselves for hormone treatment to transition from a female to a male body, PCOS is relatively prevalent.

     Since PCOS is a syndrome caused by an excess of androgens – male hormones – in biological female, this again raises the issue of hormones in both gender identity and sexual orientation.  Certainly hormones could not be the sole factor determining these complex psycho-social phenomenon, but it looks like they may play a role and that the two- gender and orientation – are at least partially intertwined.

OUR OFFICE LOCATIONS

235 9th Street
Jersey City, NJ 07302
1119 Raritan Ave.
Highland Park, NJ 08904
90 West Main Street
Freehold, NJ 07728
(800) 379-9220